Explore Our Services
What We Offer
Epigenetic Profiling and Analysis
We conduct comprehensive epigenetic assessments to identify regulatory changes associated with neuropsychiatric conditions, including:
DNA methylation analysis
Histone modification mapping
Chromatin accessibility profiling
Non-coding RNA studies
Our work supports research into conditions such as Major depressive disorder, Schizophrenia, and Bipolar disorder.
Molecular Neuroscience Research
We investigate how gene regulation influences:
Synaptic plasticity
Neurodevelopment
Stress-response pathways
Neuroinflammatory processes
Using advanced genomic and transcriptomic technologies, we aim to uncover the molecular signatures underlying psychiatric vulnerability and resilience.
Biomarker Discovery
We develop and validate molecular biomarkers that may assist in:
Early risk detection
Patient stratification
Monitoring treatment response
Advancing precision psychiatry
Our biomarker research integrates epigenetic, transcriptomic, and clinical data for translational impact.Translational and Collaborative Research
Endpoint Research partners with academic institutions, healthcare providers, and biotechnology companies to translate molecular discoveries into clinical innovation.